Posted by Michael Wonder on 17 Jan 2018
UK drugs regulator plays down Brexit disruption threat
17 January 2018 - Britain’s drugs regulator said on Tuesday it would work to minimise disruption caused by the country leaving the European Union as it tried to allay some of the worst fears of pharmaceutical companies.
The highly regulated drugs industry is concerned about Brexit fallout as the EMA relocates from London to Amsterdam, creating uncertainty about drug approvals after 2019.
The Medicines and Healthcare products Regulatory Agency said in an update on its website that it hoped to have a continuing relationship with the EMA after Brexit, but if this did not happen it would be “pragmatic” in setting UK drug rules.
